Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Minnelide

Copy Product Info
😃Good
Catalog No. T12042Cas No. 1254702-87-8

Minnelide is a water-soluble tretinoin lactone prodrug with anticancer and antitumor activity that induces apoptosis and may prevent podocyte damage.Minnelide inhibits cervical cancer growth by blocking HPV-induced changes in p53 and pRb.

Minnelide

Minnelide

Copy Product Info
😃Good
Purity: 99.59%
Catalog No. T12042Cas No. 1254702-87-8
Minnelide is a water-soluble tretinoin lactone prodrug with anticancer and antitumor activity that induces apoptosis and may prevent podocyte damage.Minnelide inhibits cervical cancer growth by blocking HPV-induced changes in p53 and pRb.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$56910-14 weeks10-14 weeks
5 mg$91810-14 weeks10-14 weeks
10 mg$1,68910-14 weeks10-14 weeks
25 mgInquiry10-14 weeks10-14 weeks
50 mgInquiry10-14 weeks10-14 weeks
100 mgInquiry10-14 weeks10-14 weeks
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.59%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Minnelide is a water-soluble tretinoin lactone prodrug with anticancer and antitumor activity that induces apoptosis and may prevent podocyte damage.Minnelide inhibits cervical cancer growth by blocking HPV-induced changes in p53 and pRb.
In vitro
Minnelide (0.100 nM, 200 nM; 48 hours) decreased cell viability in vitro in the pancreatic cancer cell lines S2-013, MIA PaCa-2, S2-VP10, and Panc-1[2].
In vivo
In the orthotopic model of pancreatic cancer with MIA PaCa-2-derived human pancreatic tumors in athymic nude mice, Minnelide (0.1-0.6 mg/kg; intraperitoneal injection; once daily or twice daily) was able to inhibit pancreatic tumor growth in vivo[2].
Chemical Properties
Molecular Weight514.37
FormulaC21H25Na2O10P
Cas No.1254702-87-8
SmilesC[C@@]12[C@@]34[C@@]5([C@@](C[C@@]1([H])C6=C(C(OC6)=O)CC2)([H])O5)[C@@H]([C@@]7([C@](O7)([H])[C@]3([H])O4)C(C)C)OCOP([O-])([O-])=O.[Na+].[Na+]
Relative Density.no data available
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 10 mg/mL (19.44 mM), Sonication is recommended.
H2O: 80 mg/mL (155.53 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 1 mg/mL (1.94 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO/H2O
1mg5mg10mg50mg
1 mM1.9441 mL9.7206 mL19.4413 mL97.2063 mL
5 mM0.3888 mL1.9441 mL3.8883 mL19.4413 mL
10 mM0.1944 mL0.9721 mL1.9441 mL9.7206 mL
H2O
1mg5mg10mg50mg
20 mM0.0972 mL0.4860 mL0.9721 mL4.8603 mL
50 mM0.0389 mL0.1944 mL0.3888 mL1.9441 mL
100 mM0.0194 mL0.0972 mL0.1944 mL0.9721 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Minnelide | purchase Minnelide | Minnelide cost | order Minnelide | Minnelide chemical structure | Minnelide in vivo | Minnelide in vitro | Minnelide formula | Minnelide molecular weight